MENU
+Compare
MIST
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$1.69
Change
-$0.13 (-7.14%)
Capitalization
97.06M

MIST Milestone Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer and manufacturer of cardiovascular medicines

Industry Biotechnology
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for MIST with price predictions
Dec 17, 2024

MIST sees MACD Histogram crosses below signal line

MIST saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 04, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 39 instances where the indicator turned negative. In of the 39 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MIST moved out of overbought territory on December 03, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 12, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on MIST as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 50-day moving average for MIST moved above the 200-day moving average on November 18, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MIST advanced for three days, in of 248 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 140 cases where MIST Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MIST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.976) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). MIST has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (74.074) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MIST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MIST is expected to report earnings to rise 35.71% to -18 cents per share on April 01

Milestone Pharmaceuticals MIST Stock Earnings Reports
Q4'24
Est.
$-0.19
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.05
Q1'24
Beat
by $0.05
Q4'23
Missed
by $0.01
The last earnings report on November 12 showed earnings per share of -14 cents, beating the estimate of -15 cents. With 307.22K shares outstanding, the current market capitalization sits at 97.06M.
A.I. Advisor
published General Information

General Information

a developer and manufacturer of cardiovascular medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1111 Dr. Frederik-Philips Boulevard
Phone
+1 514 336-0444
Employees
47
Web
https://www.milestonepharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GMBL0.270.03
+12.50%
Esports Entertainment Group, Inc.
NSANY5.110.53
+11.46%
Nissan Motor Co., Ltd.
TIIAY2.830.01
+0.35%
Telecom Italia S.p.A.
UNCRY20.04-0.29
-1.43%
UniCredito Spa
IVCTF0.04N/A
-9.52%
INVICTUS ENERGY LTD.

MIST and Stocks

Correlation & Price change

A.I.dvisor tells us that MIST and KRYS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MIST and KRYS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
+1.68%
KRYS - MIST
32%
Poorly correlated
+0.85%
CLDX - MIST
31%
Poorly correlated
-0.61%
BEAM - MIST
28%
Poorly correlated
-1.21%
GYRE - MIST
28%
Poorly correlated
+11.31%
IVEVF - MIST
28%
Poorly correlated
N/A
More